Peptide Cycle
A peptide cycle is a structured on/off protocol, typically 4–12 weeks on followed by 2–4 weeks off. Cycling periods prevent receptor desensitization and allow the system to reset.
Overview
The concept of a cycle comes from pharmacology research showing that continuous receptor stimulation can lead to downregulation — a reduction in receptor density or sensitivity over time, diminishing the response to continued administration. Cycling off gives receptors time to reset to baseline sensitivity. Typical research cycle lengths vary by peptide: GH-axis peptides like CJC-1295 and Ipamorelin are often cycled 12 weeks on, 4 weeks off; BPC-157 protocols commonly run 4–8 weeks on with 2–4 weeks off. The appropriate cycle length is compound-specific and depends on receptor biology and the endpoints being studied.
Related Terms
Frequently asked questions
Why do researchers cycle peptides on and off?+
Continuous receptor stimulation can cause receptor downregulation, reducing efficacy over time. Off periods allow receptor populations to recover baseline sensitivity.
How long should a typical peptide cycle last?+
It varies by compound: 4–12 weeks on with 2–4 weeks off is a common framework, but specific peptide research protocols may differ significantly.
Does every peptide need to be cycled?+
Not necessarily. Peptides with mechanisms less prone to receptor downregulation (e.g., BPC-157 in acute repair studies) may be used in shorter continuous protocols. GH-axis peptides are more commonly cycled due to pituitary axis sensitivity.